
Eris Biotech YC Application
Eris Biotech went through Y Combinator in the Winter 2024 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Winter 2024
- Industry
- HealthcareTherapeutics
- Team size
- 2
- Status
- Active
- Launched
- 2024
Founders
Rachel GarlickFounder
Evita WeagelFounder
What Eris Biotech does
We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.
Eris Biotech's YC application, reconstructed
Y Combinator application
Eris Biotech, Winter 2024 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Eris Biotech
Our drugs engage the immune system to fight tumors
We are developing small molecule cancer therapeutics that inhibit immune suppression in the tumor microenvironment. Our drugs activate patients' immune systems to attack tumors more effectively. We are initially focusing on treating mesothelioma and plan to expand to other solid tumors.
We live in Lehi, Utah, and the company is based here. We will continue to be based here after YC.
We built the company around where we live and work. Lehi gives us access to local scientific resources and space without the overhead of bigger biotech hubs.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real Eris Biotech YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Eris Biotech's public data (launch notes, founder backgrounds, product description). It shows how a company like Eris Biotech would present itself to YC, not the text they submitted.
What YC batch was Eris Biotech in?
Eris Biotech was part of the Y Combinator Winter 2024 batch.
Who founded Eris Biotech?
Eris Biotech was founded by Rachel Garlick, Evita Weagel.
What does Eris Biotech do?
Our drugs engage the immune system to fight tumors
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of Eris Biotech's application, and every other YC batch, is in YC Insights.